Shuttle Pharmaceuticals (Nasdaq: SHPH) is a clinical-stage pharmaceutical company leveraging our proprietary technology to develop novel therapies that are designed to cure cancer. Led by a best-in-class management team with significant experience in cancer treatment, we are developing a pipeline of revolutionary radiation sensitizers and immunotherapy assisting product candidates.
Investor Contact Information
401 Professional Drive, Suite 260
Gaithersburg, MD 20879
Lytham Partners, LLC